Project Grant R01TW013268
- Federal Project Grant Award Summary Yale University received a $192,364 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 4, 2025, with completion targeted for July 31, 2030. The research investigates the impact of antimalarial medications on parasite selection and drug resistance development within mosquito vectors. The project will examine how antimalarials ingested by...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of South Florida a Project Grant of $203,060 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective April 1, 2026, with completion targeted for March 31, 2028. The research project, titled "Ecology of Plasmodium Malariae Transmission in Cameroon," will deliver epidemiological surveillance and vector ecology data to advance understanding of...
- Federal Grant Award Summary Emory University received a $730,539 Project Grant from the John E. Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), awarded September 15, 2025, with completion targeted for March 31, 2030. The award supports "Building an India-Africa Network to Support Research and Control of Urban Malaria Transmission," a multi-national research and training initiative addressing the emerging threat of...
- Federal Grant Award Summary Yale University received a $1,377,692 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 13, 2026, with a completion date of March 31, 2031. The grant supports research aimed at deciphering residual malaria transmission mechanisms in the Peruvian Amazon to inform novel and effective control strategies. The Loreto region of Peru accounts for...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $1,351,924 to The Regents of the University of California, San Francisco under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 11, 2025, for a project titled "Characterizing the Interaction Between Human and Vector Behaviors to Enhance the Impact of Malaria Control Interventions in Uganda." The award, which extends through July 31, 2030, funds research to...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $451,000 to the University of California, San Francisco under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 15, 2025, with completion scheduled for July 31, 2027. This Project Grant supports the development and application of high-resolution phage immunoprecipitation sequencing (PhIP-Seq) arrays designed to comprehensively evaluate antibody responses to...
- Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant of $107,542 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period September 1, 2025, through August 31, 2027. The award supports investigator-initiated biomedical research examining the differential sorting and trafficking mechanisms of Plasmodium falciparum secreted proteins, with particular focus on how...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Regents of the University of California, San Francisco a $246,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective May 1, 2026, through April 30, 2028. This research initiative, titled "Malaria Importation and the Role of Agriculture in Local Transmission in Eswatini (MIRA)," delivers advanced parasitological research services and...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Washington University in St. Louis a Project Grant totaling $545,236 (awarded July 16, 2025; completion date January 31, 2027) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct investigator-initiated biomedical research on heme homeostasis in the malaria parasite Plasmodium falciparum. The research addresses the critical public health challenge of...
- Federal Grant Award Summary The University of South Florida received a $412,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 3, 2025 through June 30, 2027. The award supports research focused on evaluating immunodominant fragments of Plasmodium falciparum Glutamic Acid Rich Protein (PfGARP) for malaria vaccine development. The project builds on prior laboratory...
New York University received a $352,497 Project Grant award from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective June 1, 2026 through May 31, 2031. The award supports the Malaria Reservoir Study (MRS) II, a research initiative designed to investigate strategies for reducing parasite diversity in Plasmodium falciparum populations to enhance malaria intervention effectiveness in sub-Saharan Africa. The research addresses the critical public health challenge posed by asymptomatic malaria reservoirs and tests the hypothesis that progress toward falciparum malaria elimination should prioritize reducing antigenically diverse parasite strains. The project delivers integrated research services combining field surveillance, molecular characterization, and computational modeling conducted in Northern Ghana. The research framework includes longitudinal surveys of parasite diversity, novel molecular surveillance metrics for variant antigen characterization, and computational models encompassing both generalized and variant antigen immunity dynamics. The deliverables align with FIC's mandate to support global health research partnerships, capacity building, and evidence-based interventions addressing infectious disease challenges in resource-limited settings, while simultaneously addressing U.S. health security and strategic interests related to malaria control in economically and geopolitically significant regions.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $352.5k | 5/27/26 |